HK1035740A1 - A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) - Google Patents
A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)Info
- Publication number
- HK1035740A1 HK1035740A1 HK01104768.1A HK01104768A HK1035740A1 HK 1035740 A1 HK1035740 A1 HK 1035740A1 HK 01104768 A HK01104768 A HK 01104768A HK 1035740 A1 HK1035740 A1 HK 1035740A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- ucoe
- polynucleotide
- opening element
- chromatin opening
- ubiquitous chromatin
- Prior art date
Links
- 108010077544 Chromatin Proteins 0.000 title 1
- 210000003483 chromatin Anatomy 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/20—Vector systems having a special element relevant for transcription transcription of more than one cistron
- C12N2830/205—Vector systems having a special element relevant for transcription transcription of more than one cistron bidirectional
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9815879.3A GB9815879D0 (en) | 1998-07-21 | 1998-07-21 | A polynucleotide |
US10768898P | 1998-11-09 | 1998-11-09 | |
GBGB9906712.6A GB9906712D0 (en) | 1999-03-23 | 1999-03-23 | A polynucleotide |
US12741099P | 1999-04-01 | 1999-04-01 | |
GBGB9909494.8A GB9909494D0 (en) | 1999-04-23 | 1999-04-23 | A plasmid |
US13401699P | 1999-05-12 | 1999-05-12 | |
PCT/GB1999/002357 WO2000005393A2 (fr) | 1998-07-21 | 1999-07-21 | Polynucleotide comportant un element d'ouverture de la chromatine ubiquiste (ucoe) |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1035740A1 true HK1035740A1 (en) | 2001-12-07 |
Family
ID=27547316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01104768.1A HK1035740A1 (en) | 1998-07-21 | 2001-07-10 | A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP1098986B1 (fr) |
JP (4) | JP4220673B2 (fr) |
KR (3) | KR100795626B1 (fr) |
CN (1) | CN100365127C (fr) |
AU (1) | AU771111B2 (fr) |
CA (1) | CA2333852C (fr) |
HK (1) | HK1035740A1 (fr) |
MX (1) | MXPA01000830A (fr) |
WO (1) | WO2000005393A2 (fr) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1461343B (zh) | 2000-09-20 | 2012-10-31 | Emd密理博公司 | 多核苷酸 |
CA2435972C (fr) | 2001-01-26 | 2011-09-13 | University Of Lausanne | Regions se liant a la matrice nucleaire (mar) et procedes d'utilisation de celles-ci |
US7812148B2 (en) | 2001-04-05 | 2010-10-12 | Millipore Corporation | Vectors comprising CpG islands without position effect varigation and having increased expression |
KR100955756B1 (ko) * | 2001-04-05 | 2010-04-30 | 밀리포어 코포레이션 | 개량된 유전자 발현 |
ES2339428T3 (es) * | 2001-04-05 | 2010-05-20 | Millipore Corporation | Expresion de genes mejorada. |
WO2002097059A2 (fr) | 2001-05-30 | 2002-12-05 | Chromos Molecular Systems, Inc. | Plate-formes basees sur des chromosomes |
WO2002099089A1 (fr) * | 2001-06-04 | 2002-12-12 | Corixa Corporation | Compositions et procedes pour la production a grande echelle et haut rendement de proteines recombinees |
DK1806407T3 (da) | 2001-07-04 | 2010-08-16 | Chromagenics Bv | DNA-sekvenser med anti-repressoraktivitet |
JP2005512602A (ja) | 2002-01-09 | 2005-05-12 | マイノス バイオシステムズ リミテッド | トランスポゾンベクターを使用するトランスジェニック生物における誘導性転位 |
EP1513936A2 (fr) | 2002-06-14 | 2005-03-16 | Chromagenics B.V. | Utilisation de sequences de blocage de repression pour ameliorer l'expression d e genes |
CA2722998C (fr) | 2002-06-14 | 2014-12-02 | Chromagenics B.V. | Procede permettant la production simultanee de plusieurs proteines; vecteurs et cellules utilises dans ce procede |
ES2373549T3 (es) | 2002-12-18 | 2012-02-06 | Chromagenics B.V. | Método para mejorar la producción de proteínas. |
DE60312039T2 (de) | 2002-12-20 | 2007-11-08 | Chromagenics B.V. | Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können |
ATE471988T1 (de) * | 2003-02-01 | 2010-07-15 | Millipore Corp | Verbesserte genetische elemente für eine erhöhte genexpression |
PL1959011T3 (pl) | 2003-10-24 | 2012-07-31 | Selexis Sa | Wysokowydajny transfer genu i ekspresja w komórkach ssaczych przez procedurę wielokrotnej transfekcji sekwencji regionu przylegania do macierzy |
US8354251B2 (en) | 2003-12-31 | 2013-01-15 | Kalobios Pharmaceuticals, Inc. | Transactivation system for mammalian cells |
EP1967529A1 (fr) | 2004-07-20 | 2008-09-10 | Symphogen A/S | Anticorps polyclonal recombiné anti-rhesus D et procédé de production |
US8999667B2 (en) | 2004-11-08 | 2015-04-07 | Chromagenics B.V. | Selection of host cells expressing protein at high levels |
BRPI0517380A (pt) | 2004-11-08 | 2008-10-07 | Chromagenics Bv | molécula de dna, cassete de expressão, célula hospedeira, e, métodos para gerar uma célula hospedeira que expressa um polipeptìdeo de interesse e para produzir um polipeptìdeo de interesse |
US20060195935A1 (en) | 2004-11-08 | 2006-08-31 | Chromagenics B.V. | Selection of host cells expressing protein at high levels |
US8039230B2 (en) | 2004-11-08 | 2011-10-18 | Chromagenics B.V. | Selection of host cells expressing protein at high levels |
SI1809750T1 (sl) | 2004-11-08 | 2012-08-31 | Chromagenics Bv | Izbira gostiteljskih celic, ki imajo visok nivo izraĹľanja proteina |
GB0504587D0 (en) | 2005-03-05 | 2005-04-13 | Ml Lab Plc | Vectors comprising guinea pig CMV regulatory elements |
GB0509965D0 (en) * | 2005-05-17 | 2005-06-22 | Ml Lab Plc | Improved expression elements |
WO2007081336A1 (fr) * | 2006-01-13 | 2007-07-19 | Five Prime Therapeutics, Inc. | Vecteurs de mammiferes d'expression a haut niveau de proteines de recombinaison |
US7968700B2 (en) | 2006-03-20 | 2011-06-28 | Chromagenics B.V. | Expression augmenting DNA fragments, use thereof, and methods for finding thereof |
WO2008085962A2 (fr) * | 2007-01-08 | 2008-07-17 | Millipore Corporation | Méthodes de culture cellulaire destinées à la production de protéines recombinées en présence de niveaux réduits d'un ou plusieurs contaminants |
CN104531699B (zh) * | 2014-10-09 | 2017-03-15 | 河南农业大学 | 一种增强外源基因表达的猪的ucoe调控元件片段 |
KR20170099939A (ko) * | 2014-12-16 | 2017-09-01 | 가반 인스티튜트 오브 메디컬 리서치 | 시퀀싱 컨트롤 |
US11959093B2 (en) | 2017-03-19 | 2024-04-16 | Applied Stemcell, Inc. | Integration sites and uses thereof |
JP7021791B2 (ja) | 2017-04-03 | 2022-02-17 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 細胞系譜の多重定量分析のための組成物及び方法 |
EP3720958A1 (fr) * | 2017-12-07 | 2020-10-14 | Integrity Biosolutions, LLC | Éléments d'ouverture de chromatines ubiquistes modifiées et utilisations associées |
SG11202100765UA (en) * | 2018-08-15 | 2021-03-30 | Illumina Inc | Compositions and methods for improving library enrichment |
JP2022502063A (ja) * | 2018-10-02 | 2022-01-11 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 細胞系列の多重定量分析のための組成物および方法 |
WO2020223160A1 (fr) * | 2019-04-30 | 2020-11-05 | Chan Zuckerberg Biohub, Inc. | Nouvel élément d'ouverture de la chromatine pour expression génique stable à long terme |
CN112575031B (zh) * | 2019-09-29 | 2023-04-07 | 新乡医学院 | 一种遍在染色质开放表达元件、重组表达载体、表达系统及其制备方法、应用 |
CN116574735B (zh) * | 2023-07-03 | 2023-11-10 | 艾米能斯(苏州)生物科技有限公司 | 一种多核苷酸及其应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5166320A (en) | 1987-04-22 | 1992-11-24 | University Of Connecticut | Carrier system and method for the introduction of genes into mammalian cells |
GB8718779D0 (en) | 1987-08-07 | 1987-09-16 | Grosveld F G | Dna sequence & expression vector |
WO1991006666A1 (fr) | 1989-11-06 | 1991-05-16 | Cell Genesys, Inc. | Production de proteines par recombinaison homologue |
EP0532525B1 (fr) | 1990-05-18 | 1995-08-16 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Nouveaux conjugues de proteines et de polycations |
AU7906691A (en) | 1990-05-23 | 1991-12-10 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Adeno-associated virus (aav)-based eucaryotic vectors |
GB9109928D0 (en) | 1991-05-08 | 1991-07-03 | Interox Chemicals Ltd | Thickened compositions |
US5641670A (en) | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
CA2131620A1 (fr) | 1992-03-20 | 1993-09-30 | Louis C. Smith | Systeme de transport de l'adn et mode d'emploi |
US5583009A (en) | 1992-12-08 | 1996-12-10 | University Of Washington | Method of preparing recombinant proteins in transgenic animals containing metallothionein gene elements that bestow tissue-independent copy number-dependent, position-indepedent gene expression |
WO1995002698A1 (fr) | 1993-07-12 | 1995-01-26 | Life Technologies, Inc. | Compositions et procedes servant a transfecter des cellules eucaryotes |
WO1996041606A2 (fr) | 1995-06-08 | 1996-12-27 | Therexsys Limited | Compositions pharmaceutiques ameliorees utilisees pour la therapie genique |
ATE199570T1 (de) | 1996-08-16 | 2001-03-15 | Medical Res Council | Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln |
DE19651443A1 (de) | 1996-12-11 | 1998-06-18 | Hoechst Ag | Selbstverstärkende, pharmakologisch kontrollierbare Expressionssysteme |
WO1998035984A2 (fr) | 1997-02-12 | 1998-08-20 | Cobra Therapeutics Limited | Compositions et procedes pour une transfection tres efficace |
-
1999
- 1999-07-21 KR KR1020017000883A patent/KR100795626B1/ko not_active IP Right Cessation
- 1999-07-21 WO PCT/GB1999/002357 patent/WO2000005393A2/fr active IP Right Grant
- 1999-07-21 JP JP2000561339A patent/JP4220673B2/ja not_active Expired - Lifetime
- 1999-07-21 CN CNB998111554A patent/CN100365127C/zh not_active Expired - Lifetime
- 1999-07-21 MX MXPA01000830A patent/MXPA01000830A/es not_active IP Right Cessation
- 1999-07-21 EP EP99934910A patent/EP1098986B1/fr not_active Expired - Lifetime
- 1999-07-21 EP EP10183981A patent/EP2348118A1/fr not_active Withdrawn
- 1999-07-21 AU AU50534/99A patent/AU771111B2/en not_active Expired
- 1999-07-21 CA CA002333852A patent/CA2333852C/fr not_active Expired - Lifetime
-
2001
- 2001-07-10 HK HK01104768.1A patent/HK1035740A1/xx not_active IP Right Cessation
-
2004
- 2004-10-06 JP JP2004293969A patent/JP2005052149A/ja active Pending
-
2007
- 2007-10-15 KR KR1020070103583A patent/KR20070108336A/ko active Search and Examination
- 2007-11-01 JP JP2007285560A patent/JP2008109931A/ja not_active Withdrawn
-
2008
- 2008-11-28 JP JP2008305611A patent/JP2009102331A/ja not_active Withdrawn
-
2009
- 2009-09-30 KR KR1020090093097A patent/KR20090117675A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2333852C (fr) | 2007-05-29 |
CA2333852A1 (fr) | 2000-02-03 |
CN1334878A (zh) | 2002-02-06 |
WO2000005393A3 (fr) | 2000-08-17 |
KR20090117675A (ko) | 2009-11-12 |
KR20070108336A (ko) | 2007-11-09 |
JP2008109931A (ja) | 2008-05-15 |
WO2000005393A2 (fr) | 2000-02-03 |
JP4220673B2 (ja) | 2009-02-04 |
MXPA01000830A (es) | 2002-06-04 |
EP1098986A2 (fr) | 2001-05-16 |
AU5053499A (en) | 2000-02-14 |
JP2005052149A (ja) | 2005-03-03 |
KR20010083131A (ko) | 2001-08-31 |
CN100365127C (zh) | 2008-01-30 |
JP2002522027A (ja) | 2002-07-23 |
EP2348118A1 (fr) | 2011-07-27 |
EP1098986B1 (fr) | 2011-12-28 |
AU771111B2 (en) | 2004-03-11 |
JP2009102331A (ja) | 2009-05-14 |
KR100795626B1 (ko) | 2008-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1035740A1 (en) | A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) | |
PL343624A1 (en) | A closure | |
ZA9981B (en) | Hypolipidemic benzothiazepine compounds. | |
AU139140S (en) | A spoon | |
HK1027138A1 (en) | Document having a value | |
GB2355121B (en) | A stress-follower circuit configuration | |
AU136252S (en) | A can opener | |
AU136255S (en) | A can opener | |
GB9810873D0 (en) | A closure member | |
DE59914667D1 (en) | Istor | |
AU136254S (en) | A can opener | |
GB9813598D0 (en) | A head-guard | |
GB9815879D0 (en) | A polynucleotide | |
GB2342890B (en) | A cover | |
GB2335211B (en) | Constructional element | |
GB2346465B (en) | Improved data switch | |
AU142923S (en) | A plug | |
GB9810080D0 (en) | Data switch | |
GB9810102D0 (en) | Data switch | |
GB9902149D0 (en) | A roofing element | |
GB9826920D0 (en) | Palm reader | |
GB2341470B (en) | Delayline | |
AU136435S (en) | A stripping section | |
AU134648S (en) | A cap | |
AU139238S (en) | A tallboy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20160721 |